S Navalkissoor, A Grossman - Neuroendocrinology, 2019 - karger.com
Neuroendocrine tumours (NETs) are being seen increasingly frequently, but to date only complete surgical resection is curative. However, among the various therapeutic options …
N Reed, J Balega, T Barwick, L Buckley… - European Journal of …, 2021 - Elsevier
Cervix cancer in many countries is declining and screening programmes and immunisation will reduce the incidence in the next few decades. This guideline attempts to cover …
B Kos-Kudła, W Foltyn, A Malczewska… - Endokrynologia …, 2022 - journals.viamedica.pl
Continuous progress in the diagnostics and treatment of neuroendocrine neoplasms (NENs), the emerging results of new clinical trials, and the new guidelines issued by medical …
FM Laskaratos, K Rombouts, M Caplin… - Cancer, 2017 - Wiley Online Library
Neuroendocrine tumors are a heterogeneous group of slow‐growing neoplasms arising mainly from the enterochromaffin cells of the digestive and respiratory tract. Although they …
RM Kaderli, M Spanjol, A Kollár, L Bütikofer… - JAMA …, 2019 - jamanetwork.com
Importance Multiple therapies are currently available for patients with neuroendocrine tumors (NETs), yet many therapies have not been compared head-to-head within …
B Kos-Kudła, J Blicharz-Dorniak… - Endokrynologia …, 2017 - journals.viamedica.pl
Progress in the diagnostics and therapy of gastro-entero-pancreatic (GEP) neuroendocrine neoplasms (NEN), the published results of new randomised clinical trials, and the new …
Importance Little information is available regarding the minimum number of lymph nodes needed to accurately stage patients when performing a mesenteric lymphadenectomy for …
S Vinjamuri, TM Gilbert, M Banks, G McKane… - British journal of …, 2013 - nature.com
Background: Peptide receptor radionuclide therapy (PRRT) is an established treatment for patients with metastatic neuroendocrine tumours (NETs), although which factors are …
F Panzuto, A Lamarca, N Fazio - Cancer Treatment Reviews, 2024 - Elsevier
This review presents a comprehensive comparative analysis of international guidelines for managing advanced, non-functioning, well-differentiated pancreatic neuroendocrine tumors …